Bone-targeted therapies to reduce skeletal morbidity in prostate cancer by Tanya B Dorff, Neeraj Agarwal

Get full text

Recent developments in the treatment of non-metastatic castration resistant prostate cancer by John Esther, Tanya B. Dorff, Benjamin L. Maughan

Get full text

Review: Targeted therapy in renal cancer by Tanya B. Dorff, Amir Goldkorn, David I. Quinn

Get full text

The new era of prostate-specific membrane antigen-directed immunotherapies and beyond in advanced prostate cancer: a review by Felicity C. Martin, Tanya B. Dorff, Ben Tran

Get full text

Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial by Jacqueline K. Dawson, Tanya B. Dorff, E. Todd Schroeder, Christianne J. Lane, Mitchell E. Gross, Christina M. Dieli-Conwright

Get full text

Review: Cooperative group trials — Southwest Oncology Group (SWOG) innovations in advanced prostate cancer by Tanya B. Dorff, Cathy M. Tangen, E. David Crawford, Daniel P. Petrylak, Celestia S. Higano, Derek Raghavan, David I. Quinn, Nicholas J. Vogelzang, Ian M. Thompson

Get full text

PD-L1 blockade restores CAR T cell activity through IFN-γ-regulation of CD163+ M2 macrophages by Peter P Lee, Stephen J Forman, Xiuli Wang, Tanya B Dorff, Jelani C Zarif, Yukiko Yamaguchi, Jackson Gibson, Kevin Ou, Lupita S Lopez, Rachel H Ng, Neena Leggett, Vanessa D Jonsson, Catalina Martinez, Saul J Priceman

Get full text

Effect of Periodized Resistance Training on Skeletal Muscle During Androgen Deprivation Therapy for Prostate Cancer: A Pilot Randomized Trial by Jacqueline K. Dawson PhD, Tanya B. Dorff MD, Creighton Tuzon PhD, Judd C. Rice PhD, Edward Todd Schroeder PhD, Christianne J. Lane PhD, Mitchell E. Gross MD, PhD, Christina M. Dieli-Conwright PhD

Get full text